- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: melphalan
Total 817 results
-
Weill Medical College of Cornell UniversityJazz PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Relapsed Adult Acute Myeloid | Myelodysplastic Syndromes, Previously TreatedUnited States
-
Oncopeptides ABTerminatedMultiple MyelomaUnited States, France, Spain, Czechia
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompleted
-
Oncopeptides ABPrecision For MedicineCompletedMultiple MyelomaSpain, United States, France, Italy
-
Hackensack Meridian HealthCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedMultiple MyelomaUnited States
-
St. Jude Children's Research HospitalAssisi FoundationCompletedLymphoma | LeukemiaUnited States
-
AmgenCompletedHealthy ParticipantsUnited States
-
Delcath Systems Inc.TerminatedHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaGermany
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research...TerminatedPhase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell TransplantMultiple MyelomaUnited States
-
Baptist Health South FloridaWithdrawnCD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies (2019-KOE-001)Acute Myeloid Leukemia | Hematologic Diseases | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Hematologic Malignancy | Chronic Myelogenous LeukemiaUnited States
-
University Health Network, TorontoCelgene Corporation; Otsuka Pharmaceutical Development & Commercialization,... and other collaboratorsCompleted
-
Italian Sarcoma GroupCompletedEwing's SarcomaItaly
-
Italian Sarcoma GroupCompleted
-
PETHEMA FoundationActive, not recruitingNewly Diagnosed Multiple MyelomaSpain
-
PETHEMA FoundationCelgene Corporation; AmgenActive, not recruitingSmoldering Multiple MyelomaSpain
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple Myeloma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
University Hospital TuebingenTerminatedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaGermany
-
University Hospitals Cleveland Medical CenterTerminated
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
University Hospital, ToulouseMinistry of Health, France; Janssen, LPCompletedMultiple MyelomaFrance, Belgium
-
Margarida Magalhaes-SilvermanNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Primary Systemic Amyloidosis | Light Chain Deposition Disease | Extramedullary Plasmacytoma | Isolated Plasmacytoma of BoneUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
Philogen S.p.A.Eudax S.r.l.; InnoPharma Inc.CompletedPatients With Intransit Stage III/IV MelanomaItaly
-
Oncopeptides ABPRA Health SciencesTerminatedAL AmyloidosisSpain, United Kingdom, Germany, Norway, Israel, France, United States, Czechia, Greece
-
Delcath Systems Inc.Active, not recruitingBile Duct Cancer | Intrahepatic CholangiocarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedAnaplastic Oligoastrocytoma | Oligoastrocytoma | Anaplastic Oligodendroglioma | Mixed GliomaUnited States
-
Organon and CoCompletedHypertension | Type 2 Diabetes Mellitus
-
Novartis PharmaceuticalsMedicines for Malaria VentureCompletedAcute Uncomplicated Plasmodium Falciparum MalariaThailand, Gabon, Mali, Uganda, Burkina Faso, India, Kenya, Mozambique, Vietnam
-
Ministry of Public Health, Democratic Republic...World Health Organization; Institut National de Recherche Biomédicale. Kinshasa... and other collaboratorsCompletedMalariaCongo, The Democratic Republic of the
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Sherif S. FaragWithdrawnMultiple Myeloma | Amyloidosis | Mucositis | Oral MucositisUnited States
-
University of Illinois at ChicagoCompletedMultiple Myeloma, Relapsed | Multiple Myeloma, Refractory to Standard TreatmentUnited States
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer ResearchCompleted
-
Masonic Cancer Center, University of MinnesotaCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid Neoplasm | Chronic Myelomonocytic Leukemia-2 | Blasts 10 Percent or More of Bone Marrow Nucleated... and other conditionsUnited States
-
University of RochesterCompletedLymphoma | Multiple Myeloma | Myelofibrosis | Solid Tumors | Hematological Disease | Immune DeficienciesUnited States
-
OHSU Knight Cancer InstituteNational Institute of Neurological Disorders and Stroke (NINDS); Oregon Health...Active, not recruitingMedulloblastoma | Recurrent Malignant Germ Cell Tumor | Recurrent Medulloblastoma | Germ Cell Tumor | Primitive Neuroectodermal Tumor | Medulloepithelioma | Recurrent Primitive Neuroectodermal Tumor | Embryonal Tumor With Multilayered Rosettes, C19MC-Altered | Recurrent Childhood Central Nervous System... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma and other conditionsUnited States
-
University of California, San FranciscoCompletedSickle Cell Disease | Hemoglobinopathies | Thalassemia | Hematologic Malignancies | Immunodeficiencies | Fanconi's Anemia | Nonmalignant Diseases | Genetic Inborn Errors of MetabolismUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic Syndromes | Leukemia, Erythroblastic, AcuteUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedHematopoietic Stem Cell TransplantationUnited States
-
Northwell HealthCompletedSickle Cell Disease | Beta Thalassemia-MajorUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedNeurotoxicity | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Roswell Park Cancer InstituteCompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Myelodysplastic/Myeloproliferative Diseases | Nonmalignant NeoplasmUnited States
-
Monica BhatiaActive, not recruitingSickle Cell Disease | Graft Versus Host DiseaseUnited States
-
University Hospital Inselspital, BerneMundipharma Medical CompanyCompleted
-
University of ArkansasAmgenTerminatedMultiple MyelomaUnited States